SciELO - Scientific Electronic Library Online

vol.16 issue1The prevalence of resilience in a group of professional nursesExperiences of being a therapy radiographer author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand



Related links

  • On index processCited by Google
  • On index processSimilars in Google


Health SA Gesondheid (Online)

On-line version ISSN 2071-9736
Print version ISSN 1025-9848

Health SA Gesondheid (Online) vol.16 n.1 Cape Town  2011




Are antiretrovirals prescribed according to the recommended prescribed daily doses in the private healthcare sector in South Africa



Norah L. Katende-KyendaI; Martie LubbeII; Juan H.P. SerfonteinII; Ilse TruterIII

IDepartment of Pharmacology, Walter Sisulu University, South Africa
IIPharmacy Practice, North-West University, South Africa
IIIPharmacy Practice, Nelson Mandela Metropolitan University, South Africa





Current antiretroviral treatment (ART) guidelines recommend different combinations that have led to major improvements in the management of HIV and AIDS in the developed and developing world. With the rapid approval of many agents, health care providers may not be able to familiarise themselves with them all. This lack of knowledge leads to increased risk of dose- prescribing errors, especially by non-HIV and AIDS specialists. The purpose of this retrospective non-experimental, quantitative drug utilisation study was to evaluate if antiretrovirals (ARVs) are prescribed according to the recommended prescribed daily doses (PDDs) in a section of the private health care sector in South Africa (SA). Analysed ARV prescriptions (49995, 81096 and 88988) for HIV and AIDS patients were claimed from a national medicine claims database for the period 1 January 2005 through to 31 December 2007. ARV prescriptions prescribed by general practitioners (GPs) with PDDs not according to the recommended ARV dosing increased dramatically, from 12.33% in 2005 to 24.26% in 2007. Those prescribed by specialists (SPs) increased from 15.46% in 2005 to 35.20% in 2006 and decreased to 33.16% in 2007. The highest percentage of ARV prescriptions with PDDs not according to recommended ARV dosing guidelines was identified in ARV regimens with lopinavir-ritonavir at a PDD of 1066.4/264 mg and efavirenz at a PDD of 600 mg prescribed to patients in the age group of Group 3 (19 years > age < 45 years). These regimens were mostly prescribed by GPs rather than SPs. There is a need for more education for all health care professionals and/or providers in the private health care sector in SA on recommended ARV doses, to avoid treatment failures, development of resistance, drug-related adverse effects and drug interactions.


Huidige riglyne vir behandeling met antiretrovirale middels beveel verskillende kombinasies aan wat tot groot verbetering in die beheer van MIV en VIGS in die ontwikkelde en ontwikkelende wêreld gelei het. Met die vinnige goedkeuring van talle nuwe middels kan dit gebeur dat verskaffers van gesondheidsorg nie kan bybly om hulle hiermee op hoogte te hou nie. Hierdie gebrek aan kennis lei tot 'n hoër risiko vir foute in die voorgeskrewe dosis en veral deur persone wat nie spesialiste in MIV en VIGS is nie. Die doel van hierdie nie-eksperimentele, retrospektiewe, kwantitatiewe studie van die gebruik van geneesmiddels was om te bepaal of antiretrovirale middels in 'n deel van die privaat gesondheidsorgsektor in Suid-Afrika (SA) volgens die aanbevole voorgeskrewe daaglikse dosisse (VDD) voorgeskryf word. Voorskrifte van antiretrovirale middels (49995, 81096 en 88988) aan pasiënte met MIV en VIGS wat in die periode van 1 Januarie 2005 tot 31 Desember 2007 van 'n nasionale medisyne databasis geëis is, is ontleed. Voorskrifte van antiretrovirale middels deur algemene praktisyns (APs) met VDDs wat nie volgens die aanbevole dosisse vir antiretrovirale middels was nie, het dramaties van 12.33% in 2005 tot 24.26% in 2007 toegeneem. Die wat deur spesialiste (SPs) voorgeskryf is, het van 15.46% in 2005 tot 35.20% in 2006 toegeneem en in 2007 tot 33.16% gedaal. Die hoogste persentasie van voorskrifte vir antiretrovirale middels met VDDs wat nie volgens die riglyne was nie, was in die regimens met lopinavir-ritonavir met 'n VDD van 1066.4/264 mg en efavirens met 'n VDD van 600 mg wat aan pasiënte in die ouderdomsgroep van ouer as 19 tot en met 45 jaar voorgeskryf is. Hierdie regimens is meer deur APs as deur SPs voorgeskryf. Daar is 'n behoefte aan nog opleiding van alle gesondheidsprofessies en/of voersieners in die privaat gesondheidsorgsektor in SA oor die aanbevole antiretrovirale middel-dosisse om mislukking van behandeling, ontwikkeling van weerstand, nadelige effekte vanweë geneesmiddels en geneesmiddel interaksies te voorkom.



“Full text available only in PDF format”




Aid for Aids, 2009, 'Selecting Drug Combinations', AfA Clinical Guidelines.        [ Links ]

Anabwani, G. & Jimbo, W., 2005, Guidelines on antiretroviral treatment, rev., edn., Ministry of Health, Gaborone.         [ Links ]

Arshad, S., Rothberg, M., Rastegar, D.A., Spooner, L,M. & Daniel S.D., 2009, 'Survey of physician knowledge regarding antiretroviral medications in hospitalised HIV-infected patients', Journal of the International AIDS Society 12,1.        [ Links ]

Cameron, D.W., Japour, A.J., Xu, Y., Hsu, A., Mellors, J., Farthing, C., et al., 1999. 'Ritonavir and saquinavir combinations therapy for the treatment of HIV infection', AIDS 13, 213-224.         [ Links ]

De Maat, M., De Boer, A., Koks, C., Mulder, J.W., Meenhorst, P.L., van Gorp, E.C., et al., 2004, 'Evaluation of clinical pharmacist interventions on drug interactions in outpatient pharmaceutical HIV-care', Journal of Clinical Pharmacy & Therapeutics 29(2), 121-130.         [ Links ]

DeLorenzo, G.N., Follansbee, S.F. & Nguyen, D.P., 2005, 'Medication error in the care of HIV/AIDS patients: electronic surveillance, confirmation, and adverse events', Medical Care 43(9 suppl), 63-68.         [ Links ]

Department of Health and Human Sciences, 2008, Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents, John Hopkins University, Baltimore, viewed 09 April 2009, from        [ Links ]

Erasmus, S., 2007, 'Medical Schemes in South Africa HIV becomes prescribed minimum benefit', viewed 17 July 2007, from,30583.asp        [ Links ]

Heelon, M., Skiest, D., Tereso, G., Meade, L., Weeks, J., Pekow, P., et al., 2007, 'Effect of a clinical pharmacist's interventions on duration of antiretroviral-related errors in hospitalized patients', American Journal of Health-Systems Pharmacy 64(19), 2064-2068.         [ Links ]

Hsu, A., Granneman, G,R., Witt, G., Locke, C., Denissen, J., Molla, A., et al., 1997, 'Multiple-dose pharmacokinetics of ritonavir in human immunodeficiency virus-infected subjects', Antimicrobial Agents and Chemotherapy 41(5), 898-905.         [ Links ]

Jani, A.A., Stewart, A., Nolen, R.D. & Travel, I., 2002, 'Medication adherence and patient education in HIV/AIDS', viewed 06 May 2005, from Patient-Education.pdf        [ Links ]

Johansson, L.M., 2007, 'Fiscal implications of AIDS in South Africa', European Economic Reviews 51, 1614-1640.         [ Links ]

Johnson, L., 2006, 'Estimated numbers of patients on antiretroviral treatments in the South African private health sector', AIDS Analysis Africa Online Jan/Feb, 4-6.         [ Links ]

Malaty, L.I. & Kuper, J.J., 1999, 'Drug interactions of HIV protease inhibitors', Drug Safety 20(2), 147-169.         [ Links ]

Miller, C.D., El-Kholi, R., Faragon, J.J., Lodise, T.P., 2007, 'Prevalence and risk factors for clinically significant drug interactions with ARV therapy', Pharmacotherapy 27(10), 1379-1386.         [ Links ]

Marazzi, M.C., Bartolo, M., Gialloretti, L.E., Germano, P., Guidotti, G. & Liotta, G., et al., 2006, 'Improving adherence to highly active antiretroviral therapy in Africa: The DREAM programme in Mozambique'. Health Education Research 21(1), 34-42.         [ Links ]

Murphy, R.L., Da Silva, B.A., Hicks, C.B., Eron, J.J., Gulick, R.M., Thompson, M.A. et al., 2008, 'Seven- year efficacy of a lopinavir/ritonavir regimen in antiretroviral-naïve HIV-1-infected patients'. HIV Clinical Trials 15:9(1), 1-10.         [ Links ]

National Department of Health, 2004, Guidelines for the management of HIV-infected in South Africa, Jacana Media, Pretoria. viewed 10 March 2009, from        [ Links ]

National Department of Health South Africa, 2005, National Antiretroviral Treatment Guidelines. ARV choices for children. Guidelines for the management of HIV-infected children, Jacana Media, Pretoria.         [ Links ]

Palella, F.J., Delaney, K.M., Moorman, A.C., Loveless, M.O., Fuhrer, J., Satten, G.A., et al., 1998, 'Declining morbidity and mortarity among patients with advanced human immunodeficiency virus infection', New England Journal of Medicine 338, 853-860.         [ Links ]

Potcho, Y., Tchamdja, K., Balogou, A., Pitche, V., Guissou, I. P. & Kassang, E.K., 2010, 'Knowledge and adherence to antiretroviral therapy among adult people living with HIV/AIDS treated in the health care centres of the association "Espoir Vie Togo," West Africa', BMC Clinical Pharmacology 10, 11, viewed 16 September 2009, from        [ Links ]

Purdy, B.D., Raymond, A.M. & Lesar, T.S., 2000, 'Antiretroviral prescribing errors in hospitalised patients', Annals of Pharmacotherapy 34, 833-838.         [ Links ]

Seden, K., Back, D. & Khoo, S., 2009, 'Antiretroviral drug interaction: often recognized, Frequently unavoidable, sometimes unmanageable', Journal of Antimicrobial Chemotherapy 64, 5-8.         [ Links ]

Snyman, J.R., 2009, 'Antimicrobials: Anti-viral agents' in J.R. Snyman (ed.), MimsTM Monthly Index of Medical Specialities 47(3),359-371, Jonnic Mims, Pinegowrie.         [ Links ]

South African HIV Clinicians Society, 2009, 'South African HIV Clinicians Society Clinical Guidelines: Antiretroviral therapy in Adults', viewed 25 January 2009, from        [ Links ]

Tourret, J., Tostivint, I., Du Montcel, S.T., Karie, S., Launay-Vacher, V., Vigneau, C., et al. 2007, 'Antiretroviral drug dosing errors in HIV-infected patients undergoing hemodialysis', Clinical Infectious Diseases 15(45), 779-784.         [ Links ]

UNAIDS/World Health Organization, 2007, 'AIDS epidemic update', viewed 06 November 2009, from        [ Links ]

Ward, D.E & Kim, M., 1999, The complete guide to understanding HIV and AIDS, The AmFAR AIDS Handbook, Norton, New York.         [ Links ]

Welz, T., Hosegood, V., Jaffar, S., Batzing-Feigenbaum, J., Herbst, K. & Newell, M,L., 2007, 'Continued very high prevalence of HIV infection in rural KwaZulu-Natal, South Africa: A population-based longitudinal study', AIDS 21(11), 1467-1472.         [ Links ]

WHO/UNAIDS (World Health Organisation/United Nations Program on HIV/AIDS), 2006, 'Progress of global access to HIV antiretroviral therapy', viewed 07 October 2008, from        [ Links ]

WHO (World Health Organisation), 2003, Introduction to drug utilization research, WHO, Oslo, Norway.         [ Links ]

Wong, W.K.T. & Ussher, J.M., 2008, 'Life with HIV and AIDS in the Era of effective treatments: 'It's not just about living longer', Social Theory & Health 6, 117-131.         [ Links ]



Norah Katende-Kyenda
Private Bag X1
Mthatha, Eastern Cape
South Africa

Received: 08 June 2011
Accepted: 20 Sept. 2011
Published: 16 Nov. 2011

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License